RxDoctor Payments Data

Ramandeep Behniwal

Psychiatric/Mental Health · Moorpark, CANPI 1508527458

Payments from drug & device makers

$660in general payments, 2019–2025

Across 27 payments — averaging $24.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$203
  • E.r. Squibb & Sons, L.L.C.$125
  • AbbVie$120
  • Vanda Pharmaceuticals Inc.$38
  • Bausch Health US, LLC$38
  • Otsuka America Pharmaceutical, Inc.$20
  • plus $116 from 8 others

What the payments were for

  • Food & beverage$660100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$660 in reported general payments places this provider in the 60th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Medicare billing

Part B allowed, 2024
$22,579
Medicare patients
58
Services billed
165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole50$1,662
Quetiapine Fumarate70$1,465
Bupropion XlBupropion Hcl55$1,095
Divalproex Sodium12$538
Duloxetine Hcl27$427
Alprazolam64$419
Sertraline Hcl32$398
Buspirone Hcl17$381
Olanzapine11$326
Escitalopram Oxalate57$324
Lorazepam32$300
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine13$270
Lamotrigine24$252
Venlafaxine Hcl ErVenlafaxine Hcl18$227
Temazepam17$217

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Moorpark

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →